A molecular docking study of EGCG and theaflavin digallate with the druggable targets of SARS-CoV-2
Author:
Funder
National Institutes of Health
Publisher
Elsevier BV
Subject
Health Informatics,Computer Science Applications
Reference38 articles.
1. From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design;Hilgenfeld;FEBS J.,2014
2. The spike protein of SARS-CoV - a target for vaccine and therapeutic development;Du;Nat. Rev. Microbiol.,2009
3. Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity;Harcourt;J. Virol.,2004
4. State-of-the-art tools to identify druggable protein ligand of SARS-CoV-2;Azeez;Arch. Med. Sci.,2020
5. State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2;Borgio;Arch. Med. Sci.,2020
Cited by 66 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Medicinal Plants as Effective Antiviral Agents and Their Potential Benefits;Natural Product Communications;2024-09
2. Exploring the Therapeutic Potential of Petiveria alliacea L. Phytochemicals: A Computational Study on Inhibiting SARS-CoV-2’s Main Protease (Mpro);Molecules;2024-05-27
3. Optimisation of biotransformation conditions of theaflavin-3’-gallate;International Food Research Journal;2024-04-30
4. Molecular Docking Studies on Phytoconstituent Isolated from Nyctanthes arbortristis Linn.;International Journal of Pharmaceutical Investigation;2024-04-02
5. The repurposing of FDA-approved drugs to stop viral replication in COVID-19 treatment: a comprehensive molecular docking and dynamics analysis;Research Journal of Biotechnology;2023-11-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3